CALIDI BIOTHERAPEUTICS INC (CLDI)

US3207033099 - Common Stock

1.36  -0.09 (-6.21%)

Premarket: 1.38 +0.02 (+1.47%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
449K45K
-89.98%
-100.00%		15.3M30.6M
100.00%		63.24M
106.67%
EBITDA
YoY % growth
-6.666M-9.45M
-41.76%		-22.868M
-141.99%		N/A
-25.07%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-6.773M-9.606M
-41.83%		-23.128M
-140.77%		-27.13M
-25.35%		-23.437M
19.16%		-26.159M
-11.62%		-28.484M
-8.89%		-31.179M
-9.46%		-35.178M
-12.82%		-22.437M
36.22%		-2.914M
87.01%		17.434M
698.26%
Operating Margin
N/A-2,139.42%-51,395.56%N/AN/AN/AN/AN/AN/A-146.65%-9.52%27.57%
EPS
YoY % growth
N/AN/AN/A-14.28-4.05
71.64%		-0.92
77.20%		-0.73
20.44%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.38
92.12%		-0.25
87.30%		-0.21
85.06%		-0.21
67.20%		-0.22
41.51%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-5.458M
44.42%		N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.65
53.57%		-0.870.2225.47%
Q2 2024
Q2Q % growth		 -1.40 -1.460.064.02%
Q1 2024
Q2Q % growth		 -2.00 -2.810.8128.70%
Q4 2023
Q2Q % growth		 -4.80 -2.09-2.71-129.56%
Q3 2023
Q2Q % growth		 -1.40 -1.730.3319.26%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 20.12%
RevenueN/A N/A N/A N/A